Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • M&A / Deals
  • OZMOSI and Planview partner to enhance pharmaceutical data integration
  • M&A / Deals

OZMOSI and Planview partner to enhance pharmaceutical data integration

Pharmaceutical Business Review

The initiative aims to link external scientific data with internal R D planning by creating a unified system that supports decision-making, improves market forecasting, and helps prioritise strategic

OtherRead full story

pharminent April 24, 2026 (Last updated: April 25, 2026)

Pharmaceutical Business Review

The initiative aims to link external scientific data with internal R D planning by creating a unified system that supports decision-making, improves market forecasting, and helps prioritise strategic

OtherRead full story

Post navigation

Previous: Cardiometabolic trials: Using expertise to turn complexity into robust results
Next: Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels

Related Stories

  • M&A / Deals

Solstice Oncology secures $225m to drive porustobart’s development for cancer

pharminent September 10, 2026
  • M&A / Deals

UK’s Claret Capital raises 575m for European biotechs

pharminent September 7, 2026
  • M&A / Deals

GSK wagers up to $1.3B on a different kind of cancer drug

pharminent September 3, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.